Back to Search
Start Over
Retraction Note: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT
- Source :
- Nature Communications, Vol 14, Iss 1, Pp 1-1 (2023)
- Publication Year :
- 2023
- Publisher :
- Nature Portfolio, 2023.
- Subjects :
- Science
Subjects
Details
- Language :
- English
- ISSN :
- 20411723
- Volume :
- 14
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Nature Communications
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.09cb3cdd535740fb87f2aab84021359e
- Document Type :
- article
- Full Text :
- https://doi.org/10.1038/s41467-023-40050-1